Outlook Wealth Advisors LLC Acquires New Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Outlook Wealth Advisors LLC bought a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) during the third quarter, according to its most recent Form 13F filing with the SEC. The fund bought 408 shares of the medical equipment provider’s stock, valued at approximately $200,000.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Highland Capital Management LLC acquired a new stake in Intuitive Surgical in the third quarter valued at $3,079,000. Elwood & Goetz Wealth Advisory Group LLC bought a new stake in shares of Intuitive Surgical in the 3rd quarter valued at about $285,000. Trueblood Wealth Management LLC increased its stake in shares of Intuitive Surgical by 4.9% in the third quarter. Trueblood Wealth Management LLC now owns 1,132 shares of the medical equipment provider’s stock valued at $556,000 after buying an additional 53 shares during the period. Bank of Stockton raised its position in shares of Intuitive Surgical by 19.0% during the third quarter. Bank of Stockton now owns 1,023 shares of the medical equipment provider’s stock worth $503,000 after acquiring an additional 163 shares during the last quarter. Finally, Lake Street Advisors Group LLC lifted its stake in shares of Intuitive Surgical by 12.0% in the third quarter. Lake Street Advisors Group LLC now owns 3,276 shares of the medical equipment provider’s stock worth $1,609,000 after acquiring an additional 352 shares during the period. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Intuitive Surgical

In related news, EVP Robert Desantis sold 188 shares of Intuitive Surgical stock in a transaction that occurred on Thursday, August 29th. The stock was sold at an average price of $482.21, for a total transaction of $90,655.48. Following the transaction, the executive vice president now owns 5,506 shares of the company’s stock, valued at $2,655,048.26. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. In other news, Director Amal M. Johnson sold 2,943 shares of the business’s stock in a transaction that occurred on Thursday, August 1st. The stock was sold at an average price of $443.30, for a total value of $1,304,631.90. Following the transaction, the director now owns 12,275 shares in the company, valued at $5,441,507.50. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Robert Desantis sold 188 shares of the stock in a transaction that occurred on Thursday, August 29th. The shares were sold at an average price of $482.21, for a total value of $90,655.48. Following the sale, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at $2,655,048.26. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 52,192 shares of company stock valued at $25,398,571 over the last ninety days. 0.90% of the stock is currently owned by insiders.

Analysts Set New Price Targets

ISRG has been the subject of several analyst reports. Wells Fargo & Company raised their price target on shares of Intuitive Surgical from $466.00 to $549.00 and gave the stock an “overweight” rating in a report on Friday, October 18th. Mizuho boosted their target price on shares of Intuitive Surgical from $440.00 to $500.00 in a report on Thursday, October 17th. Citigroup increased their price target on Intuitive Surgical from $512.00 to $560.00 and gave the stock a “buy” rating in a report on Thursday, August 22nd. Truist Financial boosted their price objective on Intuitive Surgical from $520.00 to $570.00 and gave the company a “buy” rating in a research note on Monday, October 14th. Finally, Royal Bank of Canada raised their target price on Intuitive Surgical from $525.00 to $555.00 and gave the stock an “outperform” rating in a research note on Friday, October 18th. One research analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have assigned a buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $513.74.

Intuitive Surgical Price Performance

NASDAQ:ISRG opened at $511.27 on Friday. Intuitive Surgical, Inc. has a one year low of $254.85 and a one year high of $523.34. The company has a market cap of $182.10 billion, a PE ratio of 82.20, a PEG ratio of 5.11 and a beta of 1.39. The firm has a 50-day moving average of $487.98 and a 200-day moving average of $442.67.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.